Peptide Nanofiber System for Sustained Delivery of Anti-VEGF Proteins to the Eye Vitreous

Ranibizumab is a recombinant VEGF-A antibody used to treat the wet form of age-related macular degeneration. It is intravitreally administered to ocular compartments, and the treatment requires frequent injections, which may cause complications and patient discomfort. To reduce the number of injecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaylaci, Seher, Dinç, Erdem, Aydın, Bahri, Tekinay, Ayse B., Guler, Mustafa O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141348/
https://www.ncbi.nlm.nih.gov/pubmed/37111749
http://dx.doi.org/10.3390/pharmaceutics15041264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141348/
https://www.ncbi.nlm.nih.gov/pubmed/37111749
http://dx.doi.org/10.3390/pharmaceutics15041264

Ejemplares similares